UB researchers have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden ...

Patients with nontuberculous mycobacterial pulmonary disease caused by Mycobacterium avium complex had significantly improved survival if they achieved microbiological cure at the end of treatment, ...

DRESHER, PA. (WPVI) -- We need bacteria to digest food and absorb nutrients. However, when a bacteria commonly found in soil and water gets into our lungs, it can cause trouble, in the form of a MAC ...

If you have Mycobacterium avium complex (MAC) lung disease, your doctor may suggest treatment with Arikayce. It’s a prescription drug used together with other drugs to treat MAC lung disease that’s ...

Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Paratek Pharmaceuticals NewsMORE Indices Commodities Currencies Stocks ...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious ...

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.